Neil Solomons's Insider Trades & SAST Disclosures
Neil Solomons's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 124,644 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 2, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Neil Solomons.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 124,644 | 124,644 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 72,856 | 72,856 | - | - | Restricted Stock Unit | |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 8,500 | 95,799 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 02 Mar 2022 | 4,846 | 90,953 (0%) | 0% | 12.0 | 58,200 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 100,000 | 0 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.89 per share. | 09 Nov 2021 | 100,000 | 87,299 (0%) | 0% | 28.9 | 2,889,000 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.30 per share. | 09 Nov 2021 | 100,000 | 187,299 (0%) | 0% | 5.3 | 530,000 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.17 per share. | 09 Nov 2021 | 90,000 | 97,299 (0%) | 0% | 31.2 | 2,805,300 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.06 per share. | 09 Nov 2021 | 70,000 | 157,299 (0%) | 0% | 6.1 | 424,200 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 70,000 | 0 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.17 per share. | 09 Nov 2021 | 50,000 | 87,299 (0%) | 0% | 30.2 | 1,508,500 | Common Shares |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.30 per share. | 09 Nov 2021 | 30,000 | 187,299 (0%) | 0% | 5.3 | 159,000 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 30,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.55 per share. | 09 Nov 2021 | 10,000 | 87,299 (0%) | 0% | 30.6 | 305,500 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.64 per share. | 01 Nov 2021 | 45,000 | 137,299 (0%) | 0% | 31.6 | 1,423,800 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 45,000 | 130,000 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.30 per share. | 01 Nov 2021 | 45,000 | 182,299 (0%) | 0% | 5.3 | 238,500 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.20 per share. | 10 Sep 2021 | 150,000 | 287,299 (0%) | 0% | 3.2 | 480,000 | Common Shares |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2021 | 150,000 | 2,000 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.84 per share. | 10 Sep 2021 | 150,000 | 137,299 (0%) | 0% | 19.8 | 2,976,000 | Common Shares |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.85 per share. | 25 Aug 2021 | 5,000 | 137,299 (0%) | 0% | 15.9 | 79,250 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 09 Aug 2021 | 45,000 | 142,299 (0%) | 0% | 16.0 | 721,350 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 40,000 | 0 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.49 per share. | 12 Mar 2021 | 40,000 | 187,299 (0%) | 0% | 13.5 | 539,600 | Common Stock |
| Aurinia Pharmaceuticals Inc | Neil Solomons | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 12 Mar 2021 | 40,000 | 227,299 (0%) | 0% | 3.0 | 120,800 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges